Acadesine
Acadesine (also known as AICAR, 5-Aminoimidazole-4-carboxamide ribonucleotide) is an adenosine monophosphate-activated protein kinase (AMPK) activator. It is a synthetic compound that has been studied for its potential therapeutic effects in various medical conditions, including ischemia, diabetes, and cancer.
Mechanism of Action[edit | edit source]
Acadesine works by mimicking the effects of adenosine monophosphate (AMP) in the body. It activates the AMP-activated protein kinase (AMPK) pathway, which plays a crucial role in cellular energy homeostasis. Activation of AMPK leads to increased glucose uptake, fatty acid oxidation, and mitochondrial biogenesis, which can be beneficial in conditions characterized by impaired energy metabolism.
Medical Applications[edit | edit source]
Ischemia[edit | edit source]
Acadesine has been investigated for its potential to protect against ischemic injury, particularly in the context of myocardial infarction (heart attack). By activating AMPK, Acadesine can enhance the heart's ability to cope with reduced blood flow and oxygen supply, potentially reducing the extent of tissue damage.
Diabetes[edit | edit source]
In diabetes, particularly type 2 diabetes, Acadesine's ability to improve glucose uptake and enhance insulin sensitivity makes it a compound of interest. Studies have shown that Acadesine can help lower blood glucose levels and improve metabolic profiles in diabetic models.
Cancer[edit | edit source]
Acadesine has also been explored for its anti-cancer properties. By activating AMPK, it can inhibit the growth of cancer cells and induce apoptosis (programmed cell death). This makes it a potential candidate for cancer therapy, although more research is needed to fully understand its efficacy and safety in this context.
Research and Development[edit | edit source]
Acadesine has undergone various stages of clinical trials, particularly for its cardioprotective effects during coronary artery bypass grafting (CABG) surgery. However, its development has faced challenges, and it is not currently approved for clinical use.
See Also[edit | edit source]
- AMP-activated protein kinase
- Ischemia
- Diabetes
- Cancer
- Myocardial infarction
- Coronary artery bypass grafting
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD